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Background: No study has investigated the role of inflammation in explaining the 
association between early exposures to adverse life events and depressive symptoms in 
adolescence. Method: Using data from the Avon Longitudinal Study of Parents and 
Children, we tested if inflammatory markers [serum C-reactive protein (CRP) and interleukin 
6 (IL-6)] at age 9 years mediated the association between adverse life events, measured 
separately for the prenatal (since the beginning of pregnancy) and the childhood (ages 0-9 
years) periods, and the development of depressive symptoms at ages 10-17 years. Data 
(n=4,263) were analysed using mediation analysis in a latent growth curve modelling 
framework. Results: Depressive symptoms at the beginning of adolescence (age 10) were 
associated with the number of prenatal events, the number of events around birth and the 
increase in events over time in childhood (ages 0-9), even after adjustment for confounders. 
IL-6 partially mediated the association between increasing exposure to events over time in 
childhood and depressive symptoms at the beginning of adolescence. IL-6 did not mediate 
any other association between events and symptoms. There was no evidence for mediation by 
CRP, which was generally unrelated to events. Limitations: The small size of the mediation 
effect and the robust direct effects of events prenatally and around birth suggest there are 
multiple routes from early stressors to adolescent depression. Conclusions: In the general 
adolescent population, increasing exposure to psychosocial stressors over time during 
childhood is associated with the early onset of depressive symptoms, partly via increasing 
levels of plasma IL-6. 




The early experience of adverse or stressful life events has been widely associated with 
adverse health outcomes1, 2  such as the development of mental illness including major 
depressive disorder or psychosis spectrum disorders in adolescence and young adulthood.3 In 
fact, stressful events experienced as early as during pregnancy have been found to increase 
the risk of mental health problems in the offspring4. Exposure to adverse life events, either 
prenatally or during childhood, can also increase plasma levels of inflammatory markers4-10, 
in turn associated both with the onset of depressive symptoms and with treatment response.11-
14 For example, a recent meta-analysis found that elevated levels of inflammation are partially 
responsible for treatment resistance in individuals with depression.15  
Thus, the link from early stressful life events to depression via inflammation is plausible but, 
to our knowledge, still unexplored in adolescence. One study tested the role of inflammation 
in the association between stressful life events and internalising symptoms, but did not 
investigate links beyond childhood, did not consider the role of prenatal life events and did 
not explore depressive symptomatology specifically49. No study has yet investigated if 
prenatal and childhood stressful life events are related to the development of depression 
across adolescence via increasing levels of inflammatory markers. This is a significant gap 
because knowledge about the roles of stressors and inflammation in adult depression cannot 
be assumed to directly apply to paediatric depression. First, due to shorter illness duration and 
less medical comorbidity, the associations between inflammation and depression in the youth 
population may be different from what has been documented in adults. Young people are 
typically free of illness burden or extensive histories of antipsychotic usage, linked to 
inflammation. Second, adult depression can have an age at onset in adulthood or 
childhood/adolescence, and there is some evidence that juvenile-onset (i.e., child- or 
adolescent-onset) and adult-onset depression do not have the same risk correlates and 
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precursors. For example, although genetic susceptibility to major depressive disorder does 
not differ between adult- and earlier-onset major depressive disorder 17, nor does early 
exposure to risk factors such as poverty18, 19 and parental psychopathology, 20-22 some adverse 
childhood experiences such as maltreatment, including sexual/physical abuse and neglect, can 
accelerate onset into adolescence. 16  
Therefore, adding knowledge about the association between adverse life events and 
experiences, inflammatory marker levels and the onset and course of depression in 
adolescence would help build targeted interventions. Depression is a common and serious 
disorder of adolescence.23 Lifetime prevalence of major depressive disorder increases 
dramatically from 1% of the population under age 12 to ∼17%–25% by the end of 
adolescence24,  with the greatest surge in newly emergent cases in adolescence occurring after 
age 15 years.25 It would also prevent future problems in other domains, given that juvenile-
onset depression is associated with alterations in neural development26, a host of later 
negative outcomes and pervasive dysfunction throughout life27.  
We aimed to add this knowledge by using longitudinal data from a large UK birth cohort 
study, the Avon Longitudinal Study of Parents and Children (ALSPAC). We investigated if 
higher levels of inflammatory markers in childhood (age 9 years) mediate the association 
between both prenatal and childhood (0-9 years) stressful life events and depressive 
symptoms across adolescence (ages 10-17 years). As is standard in epidemiological studies, 
we disentangled in our mediation analysis the total effect of the exposure (life events) on the 
outcome (depressive symptoms), the indirect effect of the exposure that acts through the 
mediator (inflammatory marker), and the direct effect of the exposure that is unexplained by 
that mediator.  
Study design and participants 
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ALSPAC is a prospective cohort study designed to assess environmental factors during and 
after pregnancy that might affect the development, health, or wellbeing of the child 28 
[http://www.bristol.ac.uk/alspac/researchers/our-data/; note that the study website contains 
details of all the data that is available through a fully searchable data dictionary and variable 
search tool]. It enrolled 14,541 pregnant women in the Bristol area of the UK between April 
1991 and December 1992. From the first trimester of pregnancy parents completed postal 
questionnaires about themselves and the study child’s health and development. Children were 
invited to attend annual assessment clinics, including face-to-face interviews and 
psychological and physical tests from age 7 years onwards. Additional children were 
recruited using the original enrolment definition from the participating children’s age 7 years 
onwards, increasing the number to 15,445 to date.29 Ethical approval for the study was 
obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics 
Committees. All participants provided written informed consent and there was no financial 
compensation (more details at www.alspac.bris.ac.uk). Our analytic sample included 4,263 
children (singletons and first-born twins or triplets) who had data on inflammation at age 9 
years [measured in ALSPAC with serum C-reactive protein (CRP) and interleukin 6 (IL-6)], 
did not report an infection at the time of blood collection or during the preceding week, and, 
to elucidate the link between inflammatory marker levels and risk of depression without the 
confounding burden of psychiatric comorbidities, had not received a diagnosis of any 
emotional disorder since age 7 years, when the Development and Well-Being Assessment 
(DAWBA) was first administered in ALSPAC.  
Measures 
Inflammation, age 9 years 
In ALSPAC, inflammation in childhood was measured with CRP and IL-6, two well-
established inflammatory markers30, at age 9 years during a clinic visit. Consent for 
6 
 
biological samples has been collected in accordance with the Human Tissue Act (2004). 
Blood samples were collected from nonfasting participants and were immediately spun and 
frozen at −80°C. Inflammatory markers were assayed in 2008 after a median of 7.5 years in 
storage with no previous freeze-thaw cycles during this period. IL-6 (pg/mL) was measured 
by enzyme-linked immunosorbent assay (R&D Systems) and high-sensitivity CRP (mg/L) 
was measured by automated particle-enhanced immunoturbidimetric assay (Roche). All inter-
assay coefficients of variation were less than 5%.  In the full ALSPAC sample, IL-6 values 
ranged from 0.007 to 20.051 pg/mL (n = 5,072) while CRP values ranged from 0.01 to 67.44 
mg/L (n = 5,082; for 60 of these children CRP values were over 10 mg/L). In order to 
increase the replicability and interpretability of the results, both CRP and IL-6 values were 
converted into tertiles in our analysis.  
Life events  
Pre- and post-natal stressful life events were measured in ALSPAC using, respectively, a 41- 
and a 43-event checklist (Supplementary Table S1), completed by the mother31-34. In our 
analysis we derived a total prenatal life events score using information from two time-points: 
at 18 weeks gestation (covering events since the beginning of the pregnancy) and at 8 weeks 
postpartum (covering events since 18 weeks gestation). At each time-point, a score of 0 was 
assigned if the event did not occur and a score of 1 if it did. We then calculated a total score 
capturing whether each of the 41 events ever occurred at any of the two time-points. 
Postnatally, stressful life events were measured at several time-points, including 21 months 
(covering events since the child was 8 months), 33 months (covering events since the child 
was 18 months), 47 months (covering events since the child was 33 months), 61 months 
(covering events since the child was 47 months), 73 months (covering events since the child 
was 61 months) and 110 months (covering events since the child was 73 months). At each 




Depressive symptoms were assessed using the widely-used short (13-item) version of the 
Mood and Feelings Questionnaire (MFQ)35. This self-administered questionnaire (at ages 
10.5, 12.5, 13.5, 16.5 and 17.5 years in ALSPAC) indexes symptoms experienced in the 
previous 2 weeks. Each item is scored 0 (not true), 1 (sometimes true) or 2 (true), giving a 
theoretical range of 0-26 for the total MFQ.  
Confounders  
We adjusted for several covariates known to be associated with children’s levels of 
inflammatory markers, depressive symptoms and exposure to life events. These included 
gender, ethnicity (white, non-white), parental socio-economic status, which we approximated 
by maternal education (university degree or not), and obesity status (body mass index (BMI) 
above the 95th percentile for children of the same age).36 BMI (weight (kg)/height (m)2) was 
measured during the clinic visit at age 9 years.  
Statistical analysis 
All analyses were performed in STATA 15.0 (Stata Corporation, College Station, TX, 
1997).37 First, we fitted latent growth curve models to estimate the longitudinal trajectories of 
childhood events from ages 8 to 110 months and depressive symptoms from ages 10.5 to 17.5 
years. The individual predicted values of the intercept (set at baseline) and the slope (rate of 
annual change) were then used in the mediation model. Using the predict command in 
STATA we generated predictions for the out-of-sample cases, i.e., the cases that were not 
used in the original estimation. This command uses the maximum likelihood with missing 
values (MLMV) estimation for those who had data on at least one time-point and single 
imputation for those missing information on all time-points. In this way, both the intercepts 
of childhood events and depressive symptoms (set at ages 8 months and 10.5 years, 
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respectively, as explained) and their slopes were estimated for our whole analytic sample 
(n=4,263). The individual predicted values of the intercepts and the slopes were then saved 
and used in regression models testing for mediation, separately by CRP and IL-6. 
Missingness among the confounders ranged from 1.1% (BMI) to 5.3% (maternal education). 
Confounders were then imputed (20 imputed datasets) using multiple imputation by chained 
equations (MICE)38. We assumed that missingness was dependent on observed data (missing 
at random). To predict missing data, we used all variables selected for analysis models. We 
imputed up to the analytic sample. We fitted models before and after adjustment for 
confounders, both in the imputed and the complete cases samples.  
Results  
Descriptive analysis  
Table 1 shows the descriptive characteristics of our sample, including means and proportions 
for the exposures, outcomes and covariates. As can be seen, there seemed to be an increase in 
the number of depressive symptoms by age, especially after mid-adolescence, but a relative 
stability in the number of events experienced. Correlations between the main variables and 
between all exposures and outcomes were low to moderate, as expected (Supplementary 
Table S2). 
Mediation models 
The mediation model specified to predict the slope of depressive symptoms showed no 
association of symptoms with either life events or inflammatory markers (results available on 
request). However, the model specified to predict the intercept (set at age 10.5 years) of 
depressive symptoms showed that IL-6 at age 9 years mediated part of the effect of the slope 
of adverse life events (i.e., the growth of the number of events experienced after birth until 
age 9 years). The effect was robust to the adjustment for covariates (indirect effect: β=0·01, 
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p<0·05, 95% CI=0·000-0·004; total effect: β=0·04, p<0·01, 95% CI=0·013-0·073; direct 
effect: β=0·04, p<0·01, 95% CI=0·010-0·070)a. Table 2 presents the results (direct effects) of 
our mediation model for IL-6 before and after adjustment, and in both the imputed and the 
complete cases sample. The number of prenatal events had a significant effect on the 
intercept of the trajectory of depressive symptoms, as did the intercept of the trajectory of 
postnatal events, but IL-6 did not mediate either effect, as discussed. CRP did not mediate 
any of the associations between life events and the intercept of depressive symptoms, and 
was in fact unrelated to adverse life events (Supplementary Table S3).  
Discussion 
Our study showed that, even in the general population, elevated IL-6 partially explained the 
association between increasing exposure to stressors over time in childhood and depressive 
symptoms at the beginning of adolescence. However, it found no evidence that the 
association between prenatal and very early (around birth) exposures to stressors and 
depressive symptoms was mediated by either IL-6 or CRP. Our results are therefore 
consistent with previous evidence about the link between exposure to stressors and later 
mental health problems but they also add to this evidence in three important ways: (i) they 
show an association between inflammation (IL-6) and depression in adolescence (ii) they 
point to a biological pathway (inflammation) via which increases in the number of stressors 
experienced over time in childhood may lead to depressive symptoms in adolescence, and 
(iii) they suggest that, rather than explaining the effect of prenatal maternal stress on risk of 
depression in adolescence, elevated IL-6 in children may be best be seen as an immediate 
response to a relative increase in the number of stressors encountered in childhood, in turn 
                                                          
a Using unstandardised regression coefficients, direct effect: b=0.43, SE=0.16; indirect effect: b=0.03, SE=0.01; total 




associated with depressive symptoms in early adolescence. Thus, our findings about the 
association between recent exposures to psychosocial stressors and depressive symptoms in 
adolescence via inflammation, as well as about the direct link between prenatal exposures to 
psychosocial stressors and depressive symptoms in adolescence, can help to build targeted 
interventions to reduce the risk of major depressive disorder. 41, 42  
Our study has many strengths. To the best of our knowledge, it is the first general-population 
study to test the mediating role of inflammatory markers (IL-6 and CRP) in childhood in the 
association between exposure to stressors, both prenatally and postnatally across the 
childhood years, and the subsequent development of depressive symptoms across 
adolescence. Another significant strength is that it took a broad view of stressors, by 
considering both conditions or experiences marked by misfortune (either relative or absolute) 
39 and events that are arguably developmental or universal challenges that most families or 
children encounter. Importantly, it also covered exposures to such psychosocial stressors 
comprehensively, including both events experienced by the expectant mother and her family 
throughout pregnancy and events experienced by the child and their family from birth until 
the end of the first decade of life, when inflammation was measured. Thus, it extends the 
existing evidence that has established associations in adolescence between inflammation, 
depression and recent exposures to stressors.40 
Nonetheless, there are several important study limitations. First, inflammation was only 
assessed once. Second, given the observational design, causality cannot be inferred. Although 
our findings are in line with our expectations, we cannot discount residual confounding and 
reverse causality. It is also important to consider genetic mechanisms, which offer an 
alternative, noncausal interpretation of the associations we found between exposure to 
psychosocial stressors, elevated IL-6 and increased depressive symptoms in adolescents. For 
example, genetic pathways related to the immune system predict risk for several psychiatric 
11 
 
diagnoses including depression.43 In turn, early expressions of liability to these conditions 
might increase the risk of exposure to psychosocial stressors, in line with a stress generation 
explanation44 according to which depression or depressogenic vulnerabilities can increase 
susceptibility to stressful events that are at least in part influenced by the individual. Third, 
the life events checklist did not cover specifically events experienced by the child, so our 
analyses may underestimate the impact of personal events on both inflammatory marker 
levels and depressive symptoms. Fourth, the mediation effect found was small, which 
underlines the direct impact of adverse life events on depressive symptoms and suggests that 
there are multiple routes from exposure to psychosocial stressors to depression in 
adolescence. It also underscores the importance of taking development into account when 
examining links between early exposure to stressors or adversity and circulating markers of 
inflammation. For example, a recent meta-analysis45 showed that the association between 
early life adversity and both CRP and IL-6 appears to be negligible across youth samples 
(z = 0.06 for both; confidence intervals, respectively, were [−0.01, 0.14] and [−0.17, 0.30]). 
By contrast, a meta-analysis investigating the association between childhood trauma exposure 
and circulating inflammatory markers in adulthood, published only 3 years ago in 20165, 
showed small, yet significant, effect sizes overall; z = 0.10 for CRP, z = 0.08 for IL-6, and 
z = 0.23 for TNF-α (measured in too few studies with paediatric populations to make 
definitive conclusions and not available in our sample). Development across childhood and 
adolescence must also be considered. As Kuhlman et al. note45, it is possible that in children 
upregulations in the HPA-axis may be masking the pro-inflammatory phenotype. The 
substantial alteration of the HPA-axis during pubertal development46, on the other hand, 
coupled with the emergence at around the same time of risky behaviours that increase 
inflammation such as smoking, drinking and unhealthy eating, suggests that differences in 
patterns between child and adolescent samples are likely. Future studies measuring 
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glucocorticoid concentrations in children and adolescents in addition to inflammatory 
markers could help test this. Finally, we considered, for our analysis, stressful life events as 
strictly environmental exposures. However, the now established genetic overlap between 
stressful life events and major depressive disorder suggests that their relationship may not be 
directionally causal but a consequence of common genetic effects that influence both.47 
Nonetheless, most of the stressors in the checklist we used are likely independent events (i.e., 
beyond the control of the child); the genetic overlap between major depressive disorder and 
independent life events is lower than for dependent life events 47, 48 (such as relationship 
problems or job loss, that may be, in part, the result of a person’s own behaviour). 
Conclusion 
These limitations notwithstanding, our findings suggest that increasing exposure to 
psychosocial stressors over time during the first decade of life is related to depressive 
symptoms in early adolescence, partly via increased levels of inflammatory markers. 
Importantly, the same or very similar psychosocial stressors experienced prenatally and 
around birth are also related to depressive symptoms in early adolescence, but not via 
elevated inflammation, suggesting qualitatively different pathways to adolescent depression 
by early and recent psychosocial stressors.   
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Table 1. Descriptive statistics of all study variables in the analytic sample (n=4,263) 
Continuous variables 
 N M (SD) 
Prenatal adverse life events 3,717 5.53 (2.92) 
Adverse life events 8 months 3,808 3.85 (2.51) 
Adverse life events 21 months 3,674 4.46 (2.82) 
Adverse life events 33 months 3,572 5.05 (3.04) 
Adverse life events 47 months 3,584 4.74 (3.16) 
Adverse life events 61 months 3,472 4.42 (2.97) 
Adverse life events 73 months 3,428 3.84 (2.83) 
Adverse life events 110 months 3,562 4.68 (3.14) 
MFQ score 10.5 years 3,802 3.90 (3.36) 
MFQ score 12.5 years 3,423 3.80 (3.73) 
MFQ score 13.5 years  3,099   4.62 (4.18) 
MFQ score 16.5 years 2,319 5.61 (5.43) 
MFQ score 17.5 years 2,185 6.40 (5.21) 
Inflammatory markers  
  M (SD) Range  
IL-6 total sample (pg/mL)* 4,263 1.21 (1.48) 0.00-20.05 
First IL-6 tertile  (pg/mL) 1,421 0.38 (0.12) 0.00-0.57 
Second IL-6 tertile (pg/mL) 1,421 0.79 (0.14) 0.57-1.09 
First and second IL-6  tertile (pg/mL) 2,842 0.58 (0.24) 0.00-1.09 
Third (upper) IL-6 tertile (pg/mL) 1,421 2.46 (2.04) 1.09-20.05 
CRP (mg/L)* 4,263 0.62 (1.97) 0.01-45.17 
First CRP  tertile  (mg/mL) 1,423 0.08 (0.02) 0.01-0.13 
Second CRP tertile (mg/mL) 1,419 0.21 (0.05) 0.14-0.34 
First and second CRP tertile (mg/mL) 2,842 0.15 (0.07) 0.01-0.34 
Third (upper) CRP tertile (pg/mL) 1,421 1.58 (3.20) 0.35-45.17 
Categorical variables 
 N % 
Obesity, 9 years 206 4.89 
Mother is university-educated 657 17.34 
Female 2,071 48.63 
Non-white 155 4.01 
Notes: MFQ=Mood and Feelings Questionnaire; IL-6 = interleukin 6; CRP = C-reactive protein. *Mean 
values for IL-6 and CRP are presented here for information 
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Table 2. Mediation (by IL-6) model of depressive symptoms (MFQ) 
Direct paths 
Imputed Cases (n=4,263) Complete Cases (n=3,438) 
  




Prenatal ALE  IL-6 0.00 0.00 -0.00 - 0.00 0.00 0.00 -0.00 - 0.00 
Slope of postnatal ALE  IL-6 0.25** 0.06 0.12 - 0.38 0.23** 0.06 0.10 - 0.37 
Intercept of postnatal ALE  IL-6 0.00 0.00 -0.00 - 0.01 0.00 0.00 -0.00 - 0.01 
Prenatal ALE  Intercept of MFQ 0.01* 0.00 0.00 - 0.03 0.01* 0.00 0.00 - 0.03 
Slope of postnatal ALE  Intercept of 
MFQ 
0.44** 0.16 
0.12 - 0.76 
0.45** 0.17 
0.11 - 0.79 
Intercept of postnatal ALE  Intercept 
of MFQ 
0.08** 0.01 
0.06 - 0.11 
0.08** 0.01 
0.06 - 0.11 
IL-6  Intercept of MFQ 0.14** 0.03 0.07 - 0.22 0.11** 0.04 0.03 - 0.19 
 
Fully adjusted model 1 
 
Prenatal ALE  IL-6 0.00 0.00 -0.00 - 0.00 0.00 0.00 -0.00 - 0.00 
Slope of postnatal ALE  IL-6 0.25** 0.06 0.12 - 0.38 0.23** 0.06 0.10 - 0.37 
Intercept of postnatal ALE  IL-6 0.00 0.00 -0.00 - 0.01 0.00 0.00 -0.00 - 0.01 
Prenatal ALE  Intercept of MFQ 0.01* 0.00 0.00 - 0.03 0.01 0.00 -0.001 - 0.03 
Slope of postnatal ALE  Intercept of 
MFQ 
0.43** 0.16 
0.11 - 0.76 
0.46* 0.17 
0.10 - 0.81 
Intercept of postnatal ALE  Intercept 
of MFQ 
0.08** 0.01 
0.06 - 0.11 
0.10** 0.01 
0.07 - 0.12 
IL-6  Intercept of MFQ 0.10** 0.03 0.03 - 0.18 0.07 0.04 -0.00 - 0.16 
Notes: IL-6 = interleukin 6 (upper tertile vs. rest); ALE = Adverse life events; MFQ=Mood and Feelings Questionnaire (short form); SE=Standard 
error; 95% CI=95% Confidence interval. 1 Adjusted for: gender, ethnicity, maternal education, and BMI 
* p<.05       **p<.01 
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